Skip to main content
SpringerLink
Log in

Endocannabinoids and vanilloid TRPV1 receptors

  • Chapter
Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation

Part of the book series: Progress in Inflammation Research ((PIR))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66: 101–121

    Article  PubMed  CAS  Google Scholar 

  2. Di Marzo V, Blumberg PM, Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12: 372–379

    PubMed  Google Scholar 

  3. Parolaro D, Massi P, Rubino T, Monti E (2002) Endocannabinoids in the immune system and cancer. Prostaglandins Leukot Essent Fatty Acids 66: 319–332

    Article  PubMed  CAS  Google Scholar 

  4. Rice ASC, Farquhar-Smith WP, Nagy I (2002) Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 66: 243–256

    Article  PubMed  CAS  Google Scholar 

  5. Walker JM, Huang SM (2002) Endocannabinoids in pain modulation. Prostaglandins Leukot Essent Fatty Acids 66: 235–242

    Article  PubMed  CAS  Google Scholar 

  6. Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T (2002) Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 66: 377–391

    PubMed  Google Scholar 

  7. Wiley JL, Martin BR (2002) Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chem Phys Lipids 121: 57–63

    Article  PubMed  CAS  Google Scholar 

  8. Di Marzo V, Bisogno T, De Petrocellis L (2001) Anandamide: some like it hot. Trends Pharmacol Sci 22: 346–349

    PubMed  Google Scholar 

  9. Di Marzo V, Blumberg PM, Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12: 372–379

    PubMed  Google Scholar 

  10. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ et al (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99: 8400–8405

    PubMed  CAS  Google Scholar 

  11. Evans R, Scott RH, Ross RA (2004) Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol 141: 1223–1233

    Article  PubMed  CAS  Google Scholar 

  12. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452–457

    PubMed  CAS  Google Scholar 

  13. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129: 227–230

    PubMed  CAS  Google Scholar 

  14. Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br J Pharmacol 132: 631–640

    Article  PubMed  CAS  Google Scholar 

  15. Craib SJ, Ellington HC, Pertwee RG, Ross RA (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig isolated bronchus. Br J Pharmacol 134: 30–37

    Article  PubMed  CAS  Google Scholar 

  16. Ross RA (2003) Minireview: anandamide and vanilloid TRP1 receptors. Br J Pharmacol 140: 790–801

    Article  PubMed  CAS  Google Scholar 

  17. Jennings EA, Vaughan CW, Roberts LA, Christie MJ ( 2003) The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J Physiol 548: 121–129

    Article  PubMed  CAS  Google Scholar 

  18. Ralevic V, Kendall DA, Randall MD, Smart D (2002) Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci 71: 2577–2594

    Article  PubMed  CAS  Google Scholar 

  19. Sprague J, Harrison C, Rowbotham DJ, Smart D, Lambert DG (2001) Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in Hek293 cells by capsaicin and anandamide. Eur J Pharmacol 423: 121–125

    Article  PubMed  CAS  Google Scholar 

  20. Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D (2002) Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br J Anaesthesia 89: 882–887

    CAS  Google Scholar 

  21. Andersson DA, Adner M, Hogestatt ED, Zygmunt PM (2002) Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol Pharmacol 62: 705–713

    Article  PubMed  CAS  Google Scholar 

  22. Roberts LA, Christie MJ, Connor M (2002) Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol 137: 421–428

    Article  PubMed  CAS  Google Scholar 

  23. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, Oh U (1999) Capsaicin binds to the intracellular domain of the capsaicin-Activated Ion Channel. J Neurosci 19: 529–538

    PubMed  CAS  Google Scholar 

  24. Jordt SE, Julius D (2002) Molecular basis for species specificity to ‘hot’ chili peppers. Cell 108: 421–430

    Article  PubMed  CAS  Google Scholar 

  25. Hillard CJ, Jarrahian A (2003) Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol 140: 802–808

    Article  PubMed  CAS  Google Scholar 

  26. Glaser S, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch D (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100: 4269–4274

    Article  PubMed  CAS  Google Scholar 

  27. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276: 12856–12863

    PubMed  Google Scholar 

  28. Harrison S, De Petrocellis L, Trevisani M, Benvenuti F, Bifulco M, Geppetti P, Di Marzo V (2003) Capsaicin-like effects of N-arachidonoyl dopamine in the isolated guinea pig bronchi and urinary bladder. Eur J Pharmacol 475: 107–114

    Article  PubMed  CAS  Google Scholar 

  29. Toth A, Kedei N, Wang Y, Blumberg PM (2003) Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. Life Sci 73: 487–498

    PubMed  CAS  Google Scholar 

  30. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98: 9371–9376

    Article  PubMed  CAS  Google Scholar 

  31. Orliac ML, Peroni R, Celuch SM, Adler-Grachinsky E (2002) Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. J Pharmacol Exp Therap 304: 179–184

    Google Scholar 

  32. Tucker RC, Kagaya M, Page CP, Spina D (2001) The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig Airways. Br J Pharmacol 132: 1127–1135

    Article  PubMed  CAS  Google Scholar 

  33. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM (2004) Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 14: 1118–1130

    Google Scholar 

  34. Olah Z, Karai L, Iadarola MJ (2001) Anandamide activates vanilloid receptor 1 (VR1) at acidic Ph in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 276: 31163–31170

    PubMed  CAS  Google Scholar 

  35. Hwang SW, Hawoon C, Kwak J, Lee S-Y, Kang C-J, Jung J, Cho S, Min KH, Suh Y-G, Kim G, Oh U (2000) Direct activation of capsaicin receptors by products of lipoxygenase: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97: 6155–6160

    PubMed  CAS  Google Scholar 

  36. Ahluwalia J, Yaqoob M, Urban L, Bevan S, Nagy I (2003) Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J Neurochem 84: 585–591

    Article  PubMed  CAS  Google Scholar 

  37. Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, Di Marzo V (2003) Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell Mol Life Sci 60: 607–616

    PubMed  CAS  Google Scholar 

  38. Garcia DE, Brown S, Hille B, Mackie K (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18: 2834–2841

    PubMed  CAS  Google Scholar 

  39. Chuang HH, Prescott ED, Kong HY, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D (2001) Bradykinin and nerve growth factor release the capsaicin receptor from Ptdins(4,5)P-2-mediated inhibition. Nature 411: 957–962

    Article  PubMed  CAS  Google Scholar 

  40. Netzeband JG, Conroy SM, Parsons KL, Gruol DL (1999) Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture. J Neurosci 19: 8765–8777

    PubMed  CAS  Google Scholar 

  41. Ho BY, Uezono Y, Takada S, Takase I, Izumi F (1999) Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholiase C and G-protein-coupled inwardly rectifying K+ channels. Receptors Channels 6: 363–374

    PubMed  CAS  Google Scholar 

  42. Gomez Del Pulgar T, De Ceballos ML, Guzman M, Velasco G (2002) Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 277: 36527

    Google Scholar 

  43. Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100: 685–688

    Article  PubMed  CAS  Google Scholar 

  44. Ahluwalia J, Urban L, Bevan S, Capogna M, Nagy I (2002) Cannabinoid 1 receptors are expressed by nerve growth factor — and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience 110: 747–753

    Article  PubMed  CAS  Google Scholar 

  45. Farquhar-Smith WP, Egertova M, Bradbury EJ, Mcmahon SB, Rice ASC, Elphick MR (2000) Cannabinoid CB1 receptor expression in rat spinal cord. Mol Cell Neurosci 15: 510–521

    Article  PubMed  CAS  Google Scholar 

  46. Khasabova IA, Simone DA, Seybold VS (2002) Cannabinoids attenuate depolarizationdependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience 115: 613–625

    Article  PubMed  CAS  Google Scholar 

  47. Bridges D, Rice ASC, Egertove M, Elphick MR, Winter J, Michael G (2003) Localisation of CB1 cannabinoid receptor in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience 119: 803–812

    Article  PubMed  CAS  Google Scholar 

  48. Price TJ, Helesic G, Parghi D, Hargreaves KM, Flores CM (2003) The neuronal distribution of cannabinoid receptor type one in the trigeminal ganglion of the rat. Neuroscience 120: 155–162

    Article  PubMed  CAS  Google Scholar 

  49. Khasabova IA, Harding-Rose C, Simone DA, Seybold VS (2004) Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J Neurosci 24: 1744–1753

    Article  PubMed  CAS  Google Scholar 

  50. Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti P, Bianchi A (2001) Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 21 1104–1109

    PubMed  CAS  Google Scholar 

  51. Ross RA, Coutts AA, Mcfarlane S, Irving AJ, Pertwee RG, Macewan DJ, Scott RH (2001) Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40: 221–232

    Article  PubMed  CAS  Google Scholar 

  52. Ahluwalia J, Urban L, Bevan S, Nagy I (2003). Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Neuroscience 17: 2611–2618

    Google Scholar 

  53. Richardson JD, Kilo S, Hargreaves KM (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75: 111–119

    Article  PubMed  CAS  Google Scholar 

  54. Mang CF, Erbelding D, Kilbinger H (2001) Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-Cb1 cannabinoid receptors. Br J Pharmacol 134: 161–167

    Article  PubMed  CAS  Google Scholar 

  55. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A (2000) Anandamide induces apoptosis in human cells via vanilloid receptors — evidence for a protective role of cannabinoid receptors. J Biol Chem 275: 31938–31945

    PubMed  CAS  Google Scholar 

  56. Lever IJ, Malcangio M (2002) CB1 receptor antagonist SR141716A increases capsaicinevoked release of substance P from the adult mouse spinal cord. Br J Pharmacol 135: 21–24

    PubMed  CAS  Google Scholar 

  57. Pertwee RG (2005) Inverse agonism and neutral antagonism at CB1 receptors. Life Sci 76: 1307–1324

    Article  PubMed  CAS  Google Scholar 

  58. Ellington HC, Cotter MA, Cameron NE, Ross RA (2002) The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology 42: 966–975

    Article  PubMed  CAS  Google Scholar 

  59. Jia YL, Mcleod RL, Wang X, Parra LE, Egan RW, Hey JA (2002) Anandamide induces cough in conscious guinea-pigs through VR1 receptors. Br J Pharmacol 137: 831–836

    Article  PubMed  CAS  Google Scholar 

  60. Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G-protein coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60: 155–163

    PubMed  CAS  Google Scholar 

  61. Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C (1999) Anandamide and Win 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Eur J Neurosci 11: 691–699

    Article  PubMed  CAS  Google Scholar 

  62. Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63: 699–705

    Article  PubMed  CAS  Google Scholar 

  63. Pertwee RG (2004) Novel targets for cannabinoids. Curr Neuropharm 2: 29

    Google Scholar 

  64. Zygmunt PM, Andersson DA, Hogestatt ED (2002) Δ9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. J Neurosci 22: 4720–4727

    PubMed  CAS  Google Scholar 

  65. Jordt SE, Bautista DM, Chuang HH, Mckemy DD, Zygmunt PM, Hogestatt ED, Meng ID, Julius D (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427: 260–265

    Article  PubMed  CAS  Google Scholar 

  66. Kozak KR, Marnett LJ (2002) Oxidative metabolism of endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66: 211–220

    Article  PubMed  CAS  Google Scholar 

  67. Compton DR, Martin BR (1997) The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect on anandamide in the mouse model of cannabimimetic activity. J Pharmacol Exp Ther 283: 1138–1143

    PubMed  CAS  Google Scholar 

  68. Willoughby KA, Moore SF, Martin BR, Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282: 243–247

    PubMed  CAS  Google Scholar 

  69. Nilius B, Vriens J, Prenen J, Droogmans G, Voets T (2003) TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Cell Physiol 286: C195–C205

    Google Scholar 

  70. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B (2003) Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434–439

    PubMed  CAS  Google Scholar 

  71. Yu M, Ives D, Ramesha CS (1997) Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272: 21181–21186

    PubMed  CAS  Google Scholar 

  72. Burstein SH, Rossetti RG, Yagen B, Zurier RB (2000) Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat 61: 29–41

    PubMed  CAS  Google Scholar 

  73. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277: 44877–44885

    PubMed  CAS  Google Scholar 

  74. Matias I, Chen J, De Petrocellis L, Bisogno T, Ligresti A, Fezza F, Krauss AHP, Shi L, Protzman Ce, Li C et al (2004) Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. J Pharmacol Exp Ther 309: 745–757

    Article  PubMed  CAS  Google Scholar 

  75. Smith JAM, Davis CL, Burgess GM (2000) Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A. Eur J Neurosci 12: 3250–3258

    PubMed  CAS  Google Scholar 

  76. Ross RA, Craib SJ, Stevenson LA, Pertwee RG, Henderson A, Toole J, Ellington HC (2002) Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J Pharmacol Exp Ther 301: 900–907

    Article  PubMed  CAS  Google Scholar 

  77. Ueda N, Yamamoto K, Yamamoto S, Tokunaga T, Shirakawa E, Shinkai H, Ogawa M, Sato T, Kudo I, Inoue K et al (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim Biophys Acta 1254: 127–134

    PubMed  Google Scholar 

  78. Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol 54: 180–188

    PubMed  CAS  Google Scholar 

  79. Hwang SW, Hawoon C, Kwak J, Lee S-Y, Kang C-J, Jung J, Cho S, Min KH, Suh Y-G, Kim G, Oh U (2000) Direct activation of capsaicin receptors by products of lipoxygenase: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97: 6155–6160

    PubMed  CAS  Google Scholar 

  80. Piomelli D (2001) The ligand that came from within. Trends Pharmacol Sci 22: 17–19

    Article  PubMed  CAS  Google Scholar 

  81. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee S-Y, Kim SH, Lee MG, Choi YH, Kim J et al (2002) Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99: 10150–10155

    PubMed  CAS  Google Scholar 

  82. Carr MJ, Kollarik M, Meeker SN, Undem BJ (2002) A role for Trpv1 in bradykinininduced excitation of vagal airway afferent nerve terminals. J Pharmacol Exp Ther 304: 1275–1279

    Article  CAS  Google Scholar 

  83. Veldhuis WB, Van Der Stelt M, Wadman MW, Van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JFG, Bar PR, Nicolay K, Di Marzo V (2003) Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J Neurosci 23: 4127–4133

    PubMed  CAS  Google Scholar 

  84. Kagaya M, Lamb J, Robbins J, Page CP, Spina D (2002) Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br J Pharmacol 137: 39–48

    Article  PubMed  CAS  Google Scholar 

  85. Boger DL, Sato H, Lerner AE, Hedrick MP, Fecik RA, Miyauchi H, Wilkie GD, Austin BJ, Patricelli MP, Cravatt BF (2000) Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci USA 97: 5044–5049

    Article  PubMed  CAS  Google Scholar 

  86. Van Der Stelt M, Van Kuik JA, Bari M, Van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agro A, Vliegenthart JFG, Maccarrone M (2002) Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45: 3709–3720

    PubMed  Google Scholar 

  87. O’sullivan SE, Kendall DA, Randall MD (2004) Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (Nada). Br J Pharmacol 141: 803–812

    PubMed  CAS  Google Scholar 

  88. Premkumar LS, Qi Zh, Van Buren J, Raisinghani M (2004) Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor. J Neurophysiol 91: 1442–1449

    PubMed  CAS  Google Scholar 

  89. De Petrocellis L, Orlando P, Di Marzo V (1995) Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro. Biochem Mol Biol Int 36: 1127–1133

    PubMed  Google Scholar 

  90. Fowler CJ (2004) Oleamide: a member of the endocannabinoid family? Br J Pharmacol 141: 195–196

    Article  PubMed  CAS  Google Scholar 

  91. Ahern GP (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278: 30429–30434

    Article  PubMed  CAS  Google Scholar 

  92. Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ (2002) ‘Entourage’ effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol 136: 452–458

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK

    Ruth A. Ross

Authors
  1. Ruth A. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Elan Pharmaceuticals, 800 Gateway Boulevard, South San Francisco, CA, 94080, USA

    Annika B. Malmberg

  2. NeurogesX, Inc., 981F Industrial Road, San Carlos, CA, 94070, USA

    Keith R. Bley

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Ross, R.A. (2005). Endocannabinoids and vanilloid TRPV1 receptors. In: Malmberg, A.B., Bley, K.R. (eds) Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7379-2_5

Download citation

  • DOI: https://doi.org/10.1007/3-7643-7379-2_5

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-7080-0

  • Online ISBN: 978-3-7643-7379-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation